Merck & Co., Inc.
data from 30/09/2025
Capitalization
$ 228.030 M
5.77 %
Performance
$ -28.666 M
1.18 %
| Date | Ticket | Name | Weight | Capitalization | Share number | First added | Performance ($) | Performance (%) |
|---|---|---|---|---|---|---|---|---|
| 2025/09/30 | PSNL | PERSONALIS INC | 40.16% | 91.573 M $ | 14044943 | 2024/12/31 | -561.797 K $ | -0.61 % |
| 2025/09/30 | MRNA | MODERNA INC | 26.15% | 59.621 M $ | 2308190 | 2024/12/31 | -4.062 M $ | -6.38 % |
| 2025/09/30 | KYMR | KYMERA THERAPEUTICS INC | 19.17% | 43.705 M $ | 772165 | 2024/12/31 | 10.007 M $ | 29.70 % |
| 2025/09/30 | ALEC | ALECTOR INC | 4.60% | 10.495 M $ | 3545719 | 2024/12/31 | 5.531 M $ | 111.43 % |
| 2025/09/30 | ENTRADA THERAPEUTICS INC | 4.43% | 10.091 M $ | 1739768 | 2024/12/31 | -1.601 M $ | -13.69 % | |
| 2025/09/30 | EVAXION BIOTECH A/S | 2.00% | 4.565 M $ | 1214126 | 2024/12/31 | 1.591 M $ | 53.47 % | |
| 2025/09/30 | STRO | SUTRO BIOPHARMA INC | 1.04% | 2.365 M $ | 2723509 | 2024/12/31 | 420.782 K $ | 21.64 % |
| 2025/09/30 | VRDN | VIRIDIAN THERAPEUTICS INC | 0.88% | 2.016 M $ | 93414 | 2024/12/31 | 709.946 K $ | 54.36 % |
| 2025/09/30 | LVTX | LAVA THERAPEUTICS NV | 0.79% | 1.793 M $ | 1149345 | 2024/12/31 | 275.842 K $ | 18.18 % |
| 2025/09/30 | XLO | XILIO THERAPEUTICS INC | 0.55% | 1.250 M $ | 1483758 | 2024/12/31 | 241.555 K $ | 23.94 % |
| 2025/09/30 | CARM | CARISMA THERAPEUTICS INC | 0.18% | 403.668 K $ | 1473240 | 2024/12/31 | -173.253 K $ | -30.03 % |
| 2025/09/30 | NEUPHORIA THERAPEUTICS INC | 0.05% | 118.218 K $ | 10027 | 2024/12/31 | 47.026 K $ | 66.06 % | |
| 2025/09/30 | HURA | TUHURA BIOSCIENCES | 0.02% | 34.596 K $ | 13950 | 2025/06/30 | 3.487 K $ | 11.21 % |